Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae

Biomaterials

Volumn 34, Issue 38, 2013, Pages 9960-9968

  Cipitria, Amaia ^a   Reichert, Johannes C ^b,c   Epari, Devakar R ^b   Saifzadeh, Siamak ^b   Berner, Arne ^b,d   Schell, Hanna ^a   Mehta, Manav ^a   Schuetz, Michael A ^b   Duda, Georg N ^a   Hutmacher, Dietmar W ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Orthopadische Klinik Konig Ludwig Haus   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

BMP (bone morphogenetic protein); Bone tissue engineering; Ovine animal model; Polycaprolactone

Indexed keywords

ANIMAL MODEL; BMP (BONE MORPHOGENETIC PROTEIN); BONE GRAFT SUBSTITUTES; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; MICROCOMPUTED TOMOGRAPHY; POLYCAPROLACTONE SCAFFOLDS; TRI-CALCIUM PHOSPHATES;

BIOACTIVITY; BONE; COMPUTERIZED TOMOGRAPHY; DEFECTS; DIGITAL STORAGE; GRAFTING (CHEMICAL); GRAFTS; POLYCAPROLACTONE;

SCAFFOLDS (BIOLOGY);

CALCIUM PHOSPHATE; GROWTH FACTOR; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOMECHANICS; BONE DEFECT; BONE DENSITY; BONE REGENERATION; BONE TISSUE; COMPOSITE GRAFT; CONTROLLED STUDY; COST; HISTOLOGY; IMPLANTATION; MALE; MEMBRANE MICROPARTICLE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; TIBIA DEFECT; TISSUE ENGINEERING;

ANIMALIA; OVIS; OVIS ARIES;

BMP (BONE MORPHOGENETIC PROTEIN); BONE TISSUE ENGINEERING; OVINE ANIMAL MODEL; POLYCAPROLACTONE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; OSTEOGENESIS; POLYESTERS; SHEEP; TIBIA; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84885389872     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.011     Document Type: Article

References (45)

1. Govender S., Csimma C., Genant H.K., Valentin-Opran A. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures - a prospective, controlled, randomized study of four hundred and fifty patients. JBone Jt Surg Am 2002, 84A(12):2123-2134.
2. Einhorn T.A. Clinical applications of recombinant human BMPs: early experience and future development. JBone Jt Surg Am 2003, 85A:82-88.
3. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009, 31(12):1817-1824.
4. Harwood P.J., Giannoudis P.V. Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf 2005, 4(1):75-89.
5. Mines D., Gu Y., Kou T.D., Cooper G.S. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf 2011, 20(2):111-118.
6. Lad S.P., Bagley J.H., Ugiliweneza B., Babu R., Karikari I., Patil C.G., et al. BMP and cancer risk: results of a large, propensity matched study. Neurosurgery 2012, 71(2):E554.
7. DeVine J.G., Dettori J.R., France J.C., Brodt E., McGuire R.A. The use of rhBMP in spine surgery: is there a cancer risk?. Evid Based Spine Care J 2012, 3(2):35-41.
8. Chim H., Hutmacher D.W., Chou A.M., Oliveira A.L., Reis R.L., Lim T.C., et al. Acomparative analysis of scaffold material modifications for load-bearing applications in bone tissue engineering. Int J Oral Maxillofac Surg 2006, 35(10):928-934.
9. Sawyer A.A., Song S.J., Susanto E., Chuan P., Lam C.X.F., Woodruff M.A., et al. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 2009, 30:2479-2488.
10. Swieszkowski W., Tuan B.H.S., Kurzydlowski K.J., Hutmacher D.W. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 2007, 24:489-495.
11. Shao X.X., Hutmacher D.W., Ho S.T., Goh J.C.H., Lee E.H. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials 2006, 27:1071-1080.
12. Abbah S.A., Lam C.X., Hutmacher D.W., Goh J.C., Wong H.K. Biological performance of a polycaprolactone-based scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery. Biomaterials 2009, 30(28):5086-5093.
13. Woodruff M.A., Lange C., Reichert J., Berner A., Chen F., Fratzl P., et al. Bone tissue engineering: from bench to bedside. Mater Today 2012, 15(10):430-435.
14. Pitt C.G., Chasalow F.I., Hibionada Y.M., Klimas D.M., Schindler A. Aliphatic polyesters. 1. The degradation of poly(epsilon-caprolactone) in-vivo. JAppl Polym Sci 1981, 26(11):3779-3787.
15. Pitt C.G., Gratzl M.M., Kimmel G.L., Surles J., Schindler A. Aliphatic polyesters. 2. The degradation of poly(dl-lactide), poly(epsilon-caprolactone), and their copolymers in-vivo. Biomaterials 1981, 2(4):215-220.
16. Lam C.X.F., Hutmacher D.W., Schantz J.-T., Woodruff M.A., Teoh S.H. Evaluation of polycaprolactone scaffold degradation for 6 months invitro and invivo. JBiomed Mater Res A 2009, 90(3):906-919.
17. Geesink R.G.T., Hoefnagels N.H.M., Bulstra S.K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. JBone Jt Surg Br 1999, 81B(4):710-718.
18. Reichert J., Cipitria A., Epari D., Saifzadeh S., Krishnakanth P., Berner A., et al. Atissue engineering solution for segmental defect regeneration in long bones. Sci Transl Med 2012, 4(141):141ra93.
19. Reichert J.C., Epari D.R., Wullschleger M.E., Saifzadeh S., Steck R., Lienau J., et al. Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng Part B Rev 2010, 16(1):93-104.
20. Guldberg R.E., Duvall C.L., Peister A., Oest M.E., Lin A.S.P., Palmer A.W., et al. 3D imaging of tissue integration with porous biomaterials. Biomaterials 2008, 29(28):3757-3761.
21. Epari D.R., Schell H., Bail H.J., Duda G.N. Instability prolongs the chondral phase during bone healing in sheep. Bone 2006, 38(6):864-870.
22. Heckman J.D., Ryaby J.P., McCabe J., Frey J.J., Kilcoyne R.F. Acceleration of tibial fracture-healing by noninvasive, low-intensity pulsed ultrasound. JBone Jt Surg Am 1994, 76A(1):26-34.
23. Schmitz M.A., Finnegan M., Natarajan R., Champine J. Effect of smoking on tibial shaft fracture healing. Clin Orthop Relat Res 1999, 365:184-200.
24. Boerckel J.D., Kolambkar Y.M., Dupont K.M., Uhrig B.A., Phelps E.A., Stevens H.Y., et al. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011, 32(22):5241-5251.
25. Wei G., Jin Q., Giannobile W.V., Ma P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007, 28(12):2087-2096.
26. Obert L., Deschaseaux F., Garbuio P. Critical analysis and efficacy of BMPs in long bones non-union. Injury 2005, 36:38-42.
27. Oest M.E., Dupont K.M., Kong H.-J., Mooney D.J., Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. JOrthop Res 2007, 25(7):941-950.
28. Kolambkar Y.M., Dupont K.M., Boerckel J.D., Huebsch N., Mooney D.J., Hutmacher D.W., et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011, 32(1):65-74.
29. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C., Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. JBone Jt Surg Am 1994, 76A(6):827-838.
30. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 1994, 301:302-312.
31. Cook S.D., Wolfe M.W., Salkeld S.L., Rueger D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in nonhuman-primates. JBone Jt Surg Am 1995, 77A(5):734-750.
32. Kirker-Head C.A., Gerhart T.N., Schelling S.H., Hennig G.E., Wang E., Holtrop M.E. Long-term healing of bone using recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 1995, 318:222-230.
33. Kirker-Head C.A., Gerhart T.N., Armstrong R., Schelling S.H., Carmel L.A. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop Relat Res 1998, 349:205-217.
34. Den Boer F.C., Wippermann B.W., Blokhuis T.J., Patka P., Bakker F.C., Haarman H. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. JOrthop Res 2003, 21(3):521-528.
35. Kokubo S., Mochizuki Manabu, Fukushima S., Ito T., Nozaki K., Iwai T., et al. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier. Biomaterials 2004, 25:1795-1803.
36. Regauer M., Jurgens I., Kotsianos D., Stutzle H., Mutschler W., Schieker M. New-bone formation by osteogenic protein-1 and autogenic bone marrow in a critical tibial defect model in sheep. Zentralbl Chir 2005, 130(4):338-345.
37. Lee S.C., Shea M., Battle M.A., Kozitza K., Ron E., Turek T., et al. Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix. JBiomed Mater Res 1994, 28(10):1149-1156.
38. Ripamonti U., VandenHeever B., Sampath T.K., Tucker M.M., Rueger D.C., Reddi A.H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 1996, 13(3-4):273-289.
39. Ekrol I., Hajducka C., Court-Brown C., McQueen M.M. Acomparison of rhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. Injury 2008, 39:S73-S82.
40. Cipitria A., Lange C., Schell H., Wagermaier W., Reichert J., Hutmacher D., et al. Porous scaffold architecture guides tissue formation. JBone Miner Res 2012, 27(6):1275-1288.
41. Uludag H., D'Augusta D., Golden J., Li J., Timony G., Riedel R., et al. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. JBiomed Mater Res 2000, 50(2):227-238.
42. Kanczler J.M., Oreffo R.O.C. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
43. Ten Dijke P., Fu J.Y., Schaap P., Roelen B.A.J. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. JBone Jt Surg Am 2003, 85A:34-38.
44. Takigami H., Kumagai K., Latson L., Togawa D., Bauer T., Powell K., et al. Bone formation following OP-1 implantation is improved by addition of autogenous bone marrow cells in a canine femur defect model. JOrthop Res 2007, 25(10):1333-1342.
45. Triffitt P.D., Gregg P.J. Depression of bone blood-flow after blunt trauma - a fracture study in the adult rabbit. Acta Orthop Scand 1994, 65(2):195-198.